Price Alert

Ibere Pharmaceuticals (IBER)

NYSE: IBER · Real-Time Price · USD

10.18

-0.02 (-0.20%)

At close: Mar 01, 2023, 9:58 PM

Ibere Pharmaceuticals Revenue

Ibere Pharmaceuticals reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending September 30, 2022, Ibere Pharmaceuticals generated $0 in revenue.

Revenue (ttm)

Revenue Growth

n/a

Price / Sales Ratio

Revenue / Employee

n/a

Employees

n/a

Market Cap

175.6M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	% Change
Dec 31, 2021	0	n/a

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.